About Embecta Corp. 
Embecta Corp.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 71 Schemes (50.36%)
Foreign Institutions
Held by 140 Foreign Institutions (9.1%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
222 Million
(Quarterly Results - Mar 2026)
Net Profit:
-4 Million
Pharmaceuticals & Biotechnology
USD 522 Million (Micro Cap)
3.00
NA
6.68%
-1.91
-999,999.00%
-0.85






